This Week in Emergency Medicine — Oct 6, 2026

This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.

Welcome to This Week in Emergency Medicine. This week we're covering 10 notable papers spanning prehospital resuscitation and medication safety, bedside decision tools and point-of-care ultrasound, and the economics and resource pressures shaping emergency care. Let's dive in.

We start in the prehospital world, where several papers this week ask whether the timing, intensity, and precision of what paramedics do actually changes outcomes. In the Journal of Emergency Medicine, Kim and colleagues used the Korean national cardiac arrest registry to study more than twenty thousand adults who received both prehospital epinephrine and an advanced airway [1]. They defined early epinephrine as within ten minutes of crew arrival and an early airway as within six minutes. Patients who got both early had more than double the odds of good neurological recovery and roughly double the odds of survival to discharge, compared with patients who got both late. The interesting wrinkle is that an early airway paired with late epinephrine showed no benefit at all, which the authors read as suggesting the airway advantage depends on drug timing. They are candid, though, that this interaction weakened once they accounted for resuscitation time bias, so they frame it as hypothesis-generating rather than confirmatory, and as registry data it cannot establish that changing the sequence would change outcomes. Zooming out to the system level, a systematic review in Prehospital Emergency Care by Jang and colleagues pooled ten economic evaluations of prehospital cardiac arrest strategies [2]. Early defibrillation and advanced life support delivered by trained emergency medical technicians came out cost-effective against several comparators, prehospital extracorporeal resuscitation looked more cost-effective than in-hospital extracorporeal strategies, and termination-of-resuscitation rules were also cost-effective. The broad message is that strategies which deliver advanced care earlier or avoid futile transport tend to pay for themselves, but the review flags heterogeneous comparators and strikingly thin equity reporting, with almost all of the included studies addressing less than forty percent of standard equity criteria.

Staying prehospital but moving to trauma, El-Menyar and colleagues, writing in the European Journal of Emergency Medicine, reviewed the evidence on continuous vasopressor infusions for hypotensive trauma patients before hemorrhage control [3]. They found only five retrospective studies, covering about thirty-two thousand patients, of whom about fourteen hundred received vasopressors. The findings point in different directions. Two studies found no adjusted association with mortality, while a military study found that patients given vasopressors had roughly a third of the odds of survival, and one study linked vasopressors to about five times the odds of massive transfusion and about three times the odds of trauma-induced coagulopathy. The authors rate the whole body of evidence as very low certainty, so the honest summary is that safety has not been established either way, and prospective work is needed before anyone can say who, if anyone, benefits. Rounding out this theme, Prehospital Emergency Care also carries a sobering look at pediatric dosing from Spigner and colleagues [4]. Across nine emergency medical services agencies in one mid-sized city in the United States, they checked 386 medication administrations in 240 children against protocol doses. Close to half of the administrations deviated by twenty percent or more, and roughly four in five of those deviations were underdoses. Ondansetron deviated in about 85 percent of doses, and the intranasal route carried around seven times the odds of a deviation. Notably, weight estimation error did not explain the problem; instead, fixed-dose formulations and full-vial dosing seemed to account for a large share. The authors point toward latent drivers such as protocol design and formularies rather than individual error, and they stress that the clinical significance of these deviations remains uncertain.

Our second theme is bedside decision-making, where this week's papers test tools and tests that could shorten workups or prevent unnecessary ones. In CJEM, Zelt and colleagues present a meta-analysis of the Brain Injury Guidelines, the framework that stratifies patients with radiographic traumatic brain injury to decide who needs neurosurgical consultation, repeat imaging, or transfer [5]. Pooling 23 studies of the original guidelines, the lowest-risk category ruled out neurological deterioration, neurosurgical intervention, and death with sensitivities of roughly 98 percent for each outcome. Specificity, however, was only around thirteen to fourteen percent, meaning the tool flags a great many patients who will turn out fine. The authors conclude the guidelines may help identify patients suitable for discharge without further immediate investigation and could reduce unnecessary transfers, which is particularly relevant for community and rural departments; the low specificity and limited data on newer variants are the open questions. Also in CJEM, Vincent and colleagues ran a prospective multicenter study in the most Lyme-endemic regions of Quebec, asking how often peripheral facial palsy is actually Lyme disease [6]. Of 83 patients, 68 were tested, two had a positive screening ELISA, and none were confirmed on Western blot. The authors support testing according to local guidelines but conclude that routine empiric treatment is not justified without other suggestive features. This is a small sample from one province, so it informs rather than settles the question for other endemic regions.

Point-of-care ultrasound features twice this week. In the Journal of Emergency Medicine, Ghazala and colleagues meta-analyzed thirteen studies with just over four thousand early pregnancy patients, comparing emergency physician ultrasound with radiology or obstetric ultrasound [7]. Bedside scanning was associated with about an hour shorter length of stay and roughly eighty minutes faster time to definitive diagnosis, with no statistically significant difference in missed ectopic pregnancies. That last finding deserves caution: missed ectopics are rare, the estimate was imprecise, and the authors themselves call for high-quality multicenter randomized trials to confirm safety and accuracy. A broader scoping review in CJEM from Razzaq and colleagues mapped 35 studies of gastric ultrasound in emergency and intensive care patients [8]. The applications clustered around aspiration risk before airway management, monitoring of enteral feeding, and diagnosis of conditions such as gastric outlet obstruction, volvulus, and perforated viscus, with no reported harms from scanning. As a scoping review, it maps uses rather than proving outcome benefit, and the authors emphasize that protocols and training remain unstandardized, so the pre-intubation aspiration question in particular is one to watch rather than one that is answered.

Our final theme is resources and value, with two papers in the American Journal of Emergency Medicine examining what happens when supply is constrained and where spending can be recovered. Blenden and colleagues studied more than 180 thousand discharged encounters across nine hospitals in one health system before and after the 2024 intravenous fluid shortage triggered by Hurricane Helene [9]. The share of discharged patients receiving intravenous fluids fell from about one in five to about one in fifteen, with drops across all twenty of the most common diagnoses. Length of stay rose modestly for many high-volume conditions, by somewhere between six and thirty-one minutes, and 72-hour returns increased for diabetes complications, alcohol-related disorders, and upper respiratory infections. Fluid use held steady in diabetic ketoacidosis but declined in sepsis and sickle cell vaso-occlusive crisis, which the authors argue calls for diagnosis-specific allocation during future shortages. Because only discharged patients were studied, admitted and sicker patients fall outside its scope. Shokoohi and colleagues, meanwhile, built a probabilistic cost-utility model of ultrasound-guided regional anesthesia for older adults with hip fracture [10]. In their model, adding regional anesthesia to usual care saved roughly 7,800 dollars per patient while slightly improving quality-adjusted outcomes, driven by about a day shorter hospitalization, fewer skilled nursing discharges, and delirium falling from about 35 to about 25 percent. The probability of cost-effectiveness was close to one hundred percent, with an estimated national saving of about 1.2 billion dollars. This is a model built on trial and cost inputs rather than new patient data, but it adds an economic argument to the existing clinical case for nerve blocks in this population.

If you only have time for one paper this week, make it the Brain Injury Guidelines meta-analysis in CJEM [5]. It brings more than a decade of scattered validation work into a single pooled estimate, and it sharpens the question of whether low-risk radiographic head injury can be managed without routine neurosurgical consultation or transfer.

Here is what this week's evidence adds up to in Emergency Medicine. First, the Brain Injury Guidelines appear highly sensitive for excluding deterioration, intervention, and death in the lowest-risk group, though their poor specificity and the observational base leave room for refinement. Second, emergency physician ultrasound in early pregnancy is associated with meaningfully faster care, but the reassurance about missed ectopic pregnancies rests on imprecise, mostly non-randomized data. Third, in cardiac arrest, early epinephrine paired with an early airway is associated with better neurological outcomes, yet the authors themselves call this hypothesis-generating, and economic data suggest earlier advanced care is generally good value. Fourth, prehospital vasopressors in hemorrhagic shock remain unproven and possibly harmful on very low-certainty evidence, while pediatric prehospital underdosing appears common and seems tied to system design more than individual error. Finally, supply shocks and cost models both remind us that resource decisions have measurable downstream effects, from longer stays during fluid shortages to potential savings from regional anesthesia in hip fracture.

That's your roundup for This Week in Emergency Medicine. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And if you have a paper you have been meaning to read, upload the PDF, or paste any link, at audioscholar dot C C. We will turn it into audio like this one, in any of thirty-one languages.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.